Veronika Bachanova, MD
Enriched profileProfessor of Medicine; Section Head, Malignant Hematology, Division of Hematology, Oncology and Transplantation · University of Minnesota Medical School
Veronika Bachanova is Professor of Medicine; Section Head, Malignant Hematology, Division of Hematology, Oncology and Transplantation at University of Minnesota Medical School. OpenAlex indexes 495 publications with 14,704 citations (h-index 50); ClinicalTrials.gov lists 14 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Veronika Bachanova, MD, is Professor of Medicine at University of Minnesota Medical School / Masonic Cancer Center. The public record shows 495 publications with 14,704 citations (h-index 50), centered on Leukemia (AML/ALL/CML/CLL), Lymphoma, Multiple Myeloma. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 14 companies, 3 NIH-funded awards (2009–2025).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 27 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
Sponsor: Masonic Cancer Center, University of Minnesota
- Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
Sponsor: Masonic Cancer Center, University of Minnesota
Industry payments
Updated 14 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20252 payments
- Kite Pharma, Inc.Program year20252 payments
- ADC THERAPEUTICS AMERICA, INC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
34.2%Kinase inhibitor18.3%Brukinsa37%Imbruvica37%Calquence26%Part D<11 patientsBCL-2 Inhibitor13.1%Venclexta100%Part D<11 patients+ 1 more class in this area
Dermatology
22.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor22.2%Acyclovir100%Part D≥32 patientsAnti-infectives
20.8%Short-acting sulfonamides14.3%Sulfamethoxazole-Trimethoprim100%Part D≥17 patientsAzole Antifungal3.4%Fluconazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2009–2025 per NIH RePORTER. The latest:
- Improving safety and access to immune effector cell therapy with artificial intelligence technology
University of Minnesota
FY2025$207,895R21CA286980 - Improving safety and access to immune effector cell therapy with artificial intelligence technology
University of Minnesota
FY2024$176,806R21CA286980
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/veronika-bachanova-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
umn.academia.edu/VeronikaBachanova
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umn.academia.edu ↗ - ResearchGate
researchgate.net/profile/Veronika-Bachanova
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/veronika-bachanova-9b5b8211
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
onclive.com/authors/veronika-bachanova-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →zurnal.upol.cz ↗
- PhD (doctoral studies)
University of Trnava, Slovakia
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →zurnal.upol.cz ↗ - Internal Medicine Residency
Henry Ford Hospital, Detroit, MI
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Board Certified
Internal Medicine, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mphysicians.org ↗
Editorial & leadership roles
journal and society appointments- Director
Hematologic Malignancies Tissue Bank, University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Clinical Director
Cell Therapies, Masonic Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bigtencrc.org ↗
Awards & honors
honors on the public record- Research Mentor Award
HOT (Hematology, Oncology & Transplantation) Fellows Division, University of Minnesota
2017verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomacrowd.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomacrowd.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomacrowd.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →zurnal.upol.cz ↗
- Steering Committee member
Big Ten Cancer Research Consortium, representing University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bigtencrc.org ↗ - Member
Society for Immunotherapy of Cancer (SITC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →zurnal.upol.cz ↗
Media & interviews
press, podcasts and appearances- Myeloma Crowd Radio (video interview): "NAM-NK Cells and Elotuzumab" with Veronika Bachanova
MD, PhD, University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Weisdorf, MD
University of Minnesota Medical School
Jeffrey Miller, MD
University of Minnesota Medical School
Emmanuel Antonarakis, MD
University of Minnesota Medical School
David Boulware, MD, MPH
University of Minnesota Medical School
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center